Metabolic and systemic heart diseases represent a complex intersection of multiple physiological systems, where conditions such as diabetes, obesity, and hypertension can significantly impact cardiovascular health. These systemic diseases often lead to changes in heart function, contributing to conditions like heart failure, coronary artery disease, and arrhythmias. Understanding the links between metabolic imbalances and cardiovascular outcomes is crucial for developing effective treatment strategies. Metabolic and systemic heart diseases require a multidisciplinary approach that combines pharmacological interventions, lifestyle modifications, and targeted therapies to address the root causes. By focusing on managing underlying metabolic conditions, healthcare providers can significantly reduce the risk of heart-related complications and improve long-term cardiovascular health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India